Post-translational modification patterns on β-myosin heavy chain are altered in ischemic and nonischemic human hearts

  1. Maicon Landim-Vieira
  2. Matthew C Childers
  3. Amanda L Wacker
  4. Michelle Rodriquez Garcia
  5. Huan He
  6. Rakesh Singh
  7. Elizabeth A Brundage
  8. Jamie R Johnston
  9. Bryan A Whitson
  10. P Bryant Chase
  11. Paul ML Janssen
  12. Michael Regnier
  13. Brandon J Biesiadecki
  14. J Renato Pinto
  15. Michelle S Parvatiyar  Is a corresponding author
  1. Department of Biomedical Sciences, College of Medicine, The Florida State University, United States
  2. Department of Bioengineering, College of Medicine, University of Washington, United States
  3. Department of Nutrition and Integrative Physiology, The Florida State University, United States
  4. Translational Science Laboratory, College of Medicine, The Florida State University, United States
  5. Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, United States
  6. Department of Surgery, College of Medicine, The Ohio State University, United States
  7. Department of Biological Science, The Florida State University, United States
9 figures, 5 tables and 3 additional files

Figures

Figure 1 with 1 supplement
Illustrative schematic of the integrative approaches used to identify novel post-translational modifications (PTMs) on human β-myosin heavy chain (β-MHC) and investigate their roles in cardiac muscle regulation.

De-identified human heart samples were obtained from nonfailing, ischemic heart failure, and nonischemic heart failure patients. The presence of PTMs on human β-MHC was confirmed by liquid …

Figure 1—figure supplement 1
Coomassie-stained gel of homogenized human heart tissues.

The red box indicates the band corresponding to β-myosin heavy chain (β-MHC) in the cardiac human samples analyzed here at the predicted molecular weight of ~223 kDa. The lanes are BioRad Dual …

Detailed mass spectrometry (MS)/MS spectra of acetylated human β-myosin heavy chain (β-MHC) peptide sequences.

MS/MS spectra of trypsin-digested, acetylated β-MHC peptide sequences 24–35 (K34-Ac, m/z 496.61), 55–67 (K58-Ac, m/z 705.84), 414–434 (K429-Ac, m/z 774.41), 942–952 (K951-Ac, m/z 483.57), and …

Detailed mass spectrometry (MS/MS) spectra of phosphorylated human β-myosin heavy chain (β-MHC) peptide sequences.

MS/MS specta of trypsin-digested, phosphorylated β-MHC peptide sequences 207–234 (S210-P, m/z 1007.49) and 208–234 (T215-P, m/z 964.80). b-ions and y-ions indicate N-terminal and C-terminal ions, …

Figure 4 with 2 supplements
Structural models of post-translational modifications (PTMs) on β-myosin heavy chain (β-MHC).

X-ray crystal structures of the β-MHC. In (A) a post-rigor X-ray structure was used to model K58-Ac, K213-Ac, T215-P PTMs. The four motor subdomains – the N-terminal domain (yellow), upper 50 kDa …

Figure 4—figure supplement 1
Detailed liquid chromatography-mass spectrometry (MS) spectrum of the common internal peptide sequence (IRP).

MS/MS spectrum of trypsin-digested β-myosin heavy chain (β-MHC) peptide sequence (1504–1521, m/z 974.49). b-ions and y-ions indicate N-terminal and C-terminal ions, respectively.

Figure 4—figure supplement 2
Key functional regions of cardiac β-myosin motor domain and locations of the identified post-translational modifications (PTMs).

The locations of PTMs and functional regions are annotated on a schematic of the β-myosin heavy chain (β-MHC) sequence. PTM sites are denoted with pink lines, and significant structural elements are …

Figure 5 with 1 supplement
Calculations of post-translational modification (PTM) occupancy of acetylated residues on β-myosin heavy chain (β-MHC).

Peak areas of all modified peptide sequences (MOD) were normalized to the peak area of a common internal reference peptide sequence (IRP, 1504–1521). (A) Peptide 1 sequence is shown with the site of …

Figure 5—figure supplement 1
Mass spectrometry (MS/MS) spectrum of the doubly modified peptide sequence.

The K213-Ac/T215-P-modified sequence (207–234, m/z 766.36) presented an isotope dot product (idotp) value below 0.5, which indicates that the modified peptide was detectable but not quantifiable. …

Calculations of post-translational modification (PTM) occupancy of phosphorylated residues on β-myosin heavy chain (β-MHC).

Peak areas of all modified peptide sequences (MOD) were normalized to the peak area of a common internal reference peptide sequence (IRP, 1504–1521). (A) Peptide 1 sequence is shown with …

K951-Ac increased flexibility of the myosin tail.

Structural changes in the S2 fragment caused by K951-Ac are shown in representative snapshots from molecular dynamics (MD) simulations. In the snapshots, the ribbon of residue 951 is colored red, …

K58-Ac altered the solvent-exposed surface of myosin’s SH3-like domain.

(A) Representative structural changes in the SH3 domain associated with K58-Ac are shown in the endpoint structures of one unmodified (‘K58’) and two modified (‘K58-Ac’) simulations. K58-Ac formed …

K58-Ac/T215-P altered loop 1 structure and dynamics.

Molecular dynamics (MD) snapshots in (A) show representative structures from the unmodified (K213/T215) and modified (K213-Ac/T215-P) simulations. In the unmodified simulations, the loop makes …

Tables

Table 1
Liquid chromatography-mass spectrometry (LC-MS/MS) analysis of trypsin-digested human β-myosin heavy chain (β-MHC) sequences containing acetylated residues.

*An isotope dot product (idotp) value below 0.5 denotes a detectable but not quantifiable peptide sequence. C = carbamidomethyl. Acetylated residues are highlighted in red while phosphorylated …

ProteinPeptide sequenceProteaseModified residuesModificationCalculated molecular mmassObserved m/zObserved molecular massError (ppm)Charge. idotp
β-MHC23(R)LEAQTRPFDLKK(D)36TrypsinK34Acetylation (+42)1487.82496.611486.821.33+0.99
54(R)EGGKVTAETEYGK(T)68TrypsinK58Acetylation (+42)1410.67705.841409.673.22+0.91
206(K)DQSPGKGTLEDQIIQANPALEAFGNAK(T)235TrypsinK213/T215Acetylation (+42) Phosphorylation (+80)3061.48766.373061.480.04+0.48*
413(K)GQNVQQVIYATGALAKAVYER(M)435TrypsinK429Acetylation (+42)2321.22774.412320.21–3.63+0.93
941(R)KLEDECSELKR(D)953TrypsinK951Carbamidomethyl (+57) Acetylation (+42)1448.70483.571447.690.573+0.70
1194(K)KHADSVAELGEQIDNLQR(V)1213TrypsinK1195Acetylation (+42)2065.03689.012064.01–7.43+0.95
Table 2
Liquid chromatography-mass spectrometry (LC-MS/MS) analysis of trypsin-digested human β-myosin heavy chain (β-MHC) sequences containing phosphorylated residues.

*An isotope dot product (idotp) value below 0.5 denotes a detectable but not quantifiable peptide sequence. C = carbamidomethyl. Acetylated residues are highlighted in red while phosphorylated …

ProteinPeptide sequenceProteaseModified residuesModificationCalculated molecular massObserved m/zObserved molecular massError (ppm)Chargeidotp
β-MHC206(K)KDQSPGKGTLEDQIIQANPALEAFGNAK(T)235TrypsinS210Phosphorylation (+80)3020.471007.493019.46–0.963+0.99
206(K)KDQSPGKGTLEDQIIQANPALEAFGNAK(T)235TrypsinK213/T215Acetylation (+42) Phosphorylation (+80)3061.48766.373061.480.04+0.48*
207(K)DQSPGKGTLEDQIIQANPALEAFGNAK(T)235TrypsinT215Phosphorylation (+80)2892.37964.802891.37–0.793+0.99
Table 3
Inventory of β-myosin heavy chain (β-MHC) post-translational modification (PTM) simulations.

Each row corresponds to a simulated system and reports the modifications that were made and the extent of molecular dynamics (MD) sampling.

IDPDBConditionRunsLength per run(ns)Net sampling (ns)
4DB1 unmodified4DB1Unmodified35001500
4DB1 K58-Ac4DB1K58Ac35001500
4DB1 K213-Ac/T215-P4DB1K213Ac, T215P35001500
2FXM K9512FXMUnmodified35001500
2FXM K951-Ac2FXMK951Ac35001500
Table 4
Average Cα root mean squared deviation (RMSD) values.
IDRun numberCα RMSD (Å)
4DB1 unmodified13.9 ± 0.3
23.2 ± 0.3
34.1 ± 0.3
4DB1 K58-Ac13.8 ± 0.3
23.6 ± 0.2
34.1 ± 0.5
4DB1 K213-Ac/T215-P13.5 ± 0.4
23.6 ± 0.4
33.6 ± 0.3
2FXM unmodified16.9 ± 2.4
27.5 ± 2.3
37.2 ± 2.4
2FMX K951-Ac110.8 ± 2.8
29.2 ± 2.5
310.1 ± 2.0
Author response table 1
K34WTISC HFNON-ISC HFIRPWTISC HFNON-ISC HF
17124332837933984123456288379512135683546837401636720361472WTISC HFNON-ISC HF
3044864004744357762548834883083519385624838664192282846863364.512196410.4863563.36206625
1370562884744357762548834883318975877622171635712325633310729.874638719.1006969.011359892
868551601367851041005087043054454988838021373952372360396804.12947523.27256291.374162978
2.84355673.59758452.699231843
AVG5.339979.11434.111705241
K58WTISC HFNON-ISC HFIRPWTISC HFNON-ISC HF
35637110495448224426329504379512135683546837401636720361472WTISC HFNON-ISC HF
414622496583876443386178563083519385624838664192282846863369.39024262.691079811.61016632
8714936856710632866200233189758976221716357123256333107213.4464052.35067570.233004789
80678968142589216711014323054454988838021373952372360396802.62579092.55820690.266004789
2.6413543.75023841.909478898
AVG7.025952.837556.439355856
S210WTISC HFNON-ISC HFIRPWTISC HFNON-ISC HF
379877363029264432893104379512135683546837401636720361472WTISC HFNON-ISC HF
14924676829204212383789923083519385624838664192292846863361.00096240.85407480.895772881
3582028027507396543576323318975897622171635712325633310724.84014371.17575611.356882362
2500887218092996450571963054454988838021373952372360396801.0792571.2406571.669289664
0.81876710.47586381.210004265
AVG1.934780.936591.282006889
Y215WTISC HFNON-ISC HFIRPWTISC HFNON-ISC HF
583063606039762463556984379512135683546837401636720361472WTISC HFNON-ISC HF
21447388843148672609148963083519385624838664192282846863361.53635031.70285861.730837646
40785388876148243318975897622171635712325633310726.95549021.73715752.153635196
1100631.550358960735741283054454988838021373952372260396801.839532.69059771
0.03603361.32449081.975884886
AVG2.842621.651012.137738859
K429WTISC HFNON-ISC HFIRPWTISC HFNON-ISC HF
383197446654272034278128379512135683546837401636720361472WTISC HFNON-ISC HF
3996252831968566250585883083519385624828664192282846863361.00971061.87611420.933491029
3057771829568352338883643318975897622171635712325633310721.29600381.28704850.885941873
2653174832985240308072463054454988838021373952372360396800.92129981.33361171.040690952
0.86862460.86754470.82735023
AVG1.023911.341080.921868521
K951WTISC HFNON-ISC HFIRPWTISC HFNON-ISC HF
554000765156454688274431584379512135683546837401636720361472WTISC HFNON-ISC HF
43127568010407809625446500830835193856248386641922828468633614.5977094.4111047.473555345
59453043214349184015087072033189758976221716357123256333107213.9864754.19016488.996564607
334659520210390240448039803.05446E+11380213739523723603968017.9130696.47186534.633147624
10.956445.53347281.203242353
AVG14.36345.151655.576627007
K1195WTISC HFNON-ISC HFIRPWTISC HFNON-ISC HF
772333843078283620483700379512135683546837401636720361472WTISC HFNON-ISC HF
9098412870924552591258323083519385624838664192282846863362.03507020.86789530.557829476
4430414416460342295193243318975897622171635712325633310722.95065852.85540932.09038316
64847704116297014238266523054456988838021373952372360396801.33487390.74240540.906520403
2.12305320.30587271.138215889
AVG2.110911.19291.173237232

Additional files

Supplementary file 1

Summary of the patients’ demographic features.

Deidentified human heart samples were obtained from nonfailing, ischemic heart failure, and nonischemic heart failure patients.

https://cdn.elifesciences.org/articles/74919/elife-74919-supp1-v2.docx
Supplementary file 2

Comparison of location of residues bearing post-translational modifications (PTMs) with known cardiomyopathy variants in MYH7.

List of potential pathogenicity of the variants and their location within nearby PTM regions. Cardiomyopathy-loop (CM-loop), likely pathogenic (LP), pathogenic (P), hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM).

https://cdn.elifesciences.org/articles/74919/elife-74919-supp2-v2.docx
Transparent reporting form
https://cdn.elifesciences.org/articles/74919/elife-74919-transrepform1-v2.pdf

Download links